Clinical Trial

A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is an open, single arm, single-center Phase I trial designed to evaluate the effect of seven days repeated oral doses of linaprazan glurate on the pharmacokinetics (PK) of repeated doses of amoxicillin in healthy male and female participants
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-15.
Status change: Recruiting → Completed 2026-02-26
Trial Details
NCT Number NCT07308041
Lead Sponsor Cinclus Pharma Holding AB
Conditions Drug Interaction, GERD (Gastroesophageal Reflux Disease), Safety, and Tolerability
Enrollment 12 participants
Start Date 2025-11-11
Primary Completion 2025-12-22 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2026-02-27